https://wikimd.org/index.php?action=history&feed=atom&title=Alpha_secretaseAlpha secretase - Revision history2026-04-27T04:41:03ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=Alpha_secretase&diff=5603925&oldid=prevPrab: CSV import2024-04-14T21:41:57Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:APP_cleavage.png|left|thumb]] '''Alpha secretase''' is an [[enzyme]] that plays a crucial role in the [[proteolytic processing]] of amyloid precursor protein (APP), which is significant in the context of [[neurodegenerative diseases]], particularly [[Alzheimer's disease]]. Unlike beta-secretase and gamma-secretase, which cleave APP to produce [[beta-amyloid]] peptides associated with Alzheimer's disease pathology, alpha secretase cuts APP within the amyloid domain. This cleavage prevents the formation of beta-amyloid peptides, suggesting a protective role against the development of Alzheimer's disease.<br />
<br />
==Function==<br />
Alpha secretase is involved in the non-amyloidogenic pathway by cleaving APP in the middle of the Aβ peptide sequence. This action results in the secretion of soluble APP alpha (sAPPα) and the prevention of beta-amyloid peptide formation, which is toxic to neurons. The activity of alpha secretase is not only crucial for preventing Alzheimer's disease but also plays a role in [[cell signaling]] and [[neural plasticity]], indicating its importance in normal brain function.<br />
<br />
==Types and Mechanism==<br />
There are several types of alpha secretases, including members of the [[ADAM (A Disintegrin And Metalloprotease) family]], such as ADAM10 and ADAM17. These enzymes are zinc-dependent metalloproteases that cleave their substrates at the cell surface. The exact mechanism of how alpha secretase selects APP for cleavage and its regulation is complex and involves various factors, including cellular localization, cholesterol levels, and interactions with other proteins.<br />
<br />
==Clinical Significance==<br />
The role of alpha secretase in preventing the formation of beta-amyloid plaques makes it a target of interest for therapeutic intervention in Alzheimer's disease. Enhancing alpha secretase activity or mimicking its action could potentially reduce the accumulation of beta-amyloid peptides and slow the progression of Alzheimer's disease. Research in this area focuses on identifying compounds that can increase alpha secretase activity or modulate its expression.<br />
<br />
==Research and Development==<br />
Ongoing research aims to better understand the regulation of alpha secretase and its potential as a therapeutic target. This includes studying the genetic and environmental factors that influence its activity and developing drugs that can enhance its function. Despite the promise, there are challenges in targeting alpha secretase for therapy, including the enzyme's broad substrate specificity and the potential for off-target effects.<br />
<br />
[[Category:Enzymes]]<br />
[[Category:Neurodegenerative diseases]]<br />
[[Category:Alzheimer's disease]]<br />
<br />
{{medicine-stub}}</div>Prab